Stockreport

ImmunityBio (IBRX) Extends Gains to 10th Day on 700% Anktiva Sales Jump; Time to Book Profits? [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF ImmunityBio extended its winning streak to a 10 th consecutive day on Thursday, soaring 30.79 percent to close at $3.95 apiece, as investors loaded portfolios after ach [Read more]